advertisement
Berlin MS 5
Showing records 1 to 5 | Display all abstracts from Berlin MS70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Miller Ellis E
British Journal of Ophthalmology 2017; 101: 796-800
70512 Increasing healthcare costs: can we influence the costs of glaucoma care?
Töteberg-Harms M; Berlin MS
Current Opinions in Ophthalmology 2017; 28: 127-132
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Berlin MS; Ward CL
British Journal of Ophthalmology 2017; 101: 796-800
70512 Increasing healthcare costs: can we influence the costs of glaucoma care?
Meier-Gibbons F
Current Opinions in Ophthalmology 2017; 28: 127-132
70237 Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
Sharpe JA; Jamil A; Harris A
British Journal of Ophthalmology 2017; 101: 796-800
